Podcasts about imperial college

Send us a textIn this inspiring episode, Rino Rappuoli, PhD, a true pioneer in modern vaccinology and recipient of the 2025 Maxwell Finland Award for Scientific Achievement, joins Marla Dalton, CAE, and William Schaffner, MD, to explore his groundbreaking work in vaccinology. From his early days in Siena, Italy, to leading the development of life‑saving vaccines against meningitis, pertussis, and influenza, Rappuoli has transformed how vaccines are developed. He shares insights on mentorship, the origins of reverse vaccinology, climate change, and the future role of artificial intelligence in disease prevention. Tune in for a powerful conversation about science, innovation, and the unwavering drive to protect public health.  Show NotesRappuoli is scientific director of the Biotecnopolo di Siena Foundation, Italy, honorary professor of Vaccinology at Imperial College, London, and senior professor of molecular biology at the University of Siena. He was previously head of external R&D and chief scientist at GSK Vaccines and founded the GSK Vaccines Institute for Global Health. He earned his PhD in biological sciences at the University of Siena, Italy, and was visiting scientist at Rockefeller University and Harvard Medical School. An elected member of the National Academy of Sciences, he was awarded the Albert B Sabin Gold Medal in 2009. He is currently president of the International Union of Microbiological Societies. Rappuoli is among the world's scientific leaders dedicated to the sustainability of global health and his work has contributed significantly to improving the quality of human life. Follow NFID on social media

La científica Michele Dougherty hace historia como la primera mujer Astrónoma Real del Reino Unido  Por Félix Riaño @LocutorCo   La física espacial Michele Dougherty ha sido nombrada la primera Astrónoma Real en 350 años. Su trabajo reveló indicios de vida en una luna de Saturno.  El Reino Unido acaba de nombrar, por primera vez en tres siglos y medio, a una mujer como Astrónoma Real. La profesora Michele Dougherty, nacida en Sudáfrica y actual experta en física espacial del Imperial College London, fue quien lideró investigaciones que descubrieron géiseres de agua en Encelado, una de las lunas de Saturno. Ese hallazgo hizo pensar a la comunidad científica que podría haber vida en ese lugar. Además, dirige instrumentos a bordo de la sonda JUICE, rumbo a las lunas heladas de Júpiter.¿Qué significa su nombramiento en un cargo históricamente reservado a hombres blancos?  Nunca estudió ciencias en el colegio, ni pensaba hacerlo.  Michele Dougherty nació en Sudáfrica, en una familia con herencia inglesa e irlandesa. Cuando tenía 10 años, su padre construyó un telescopio en el jardín. Ella y su hermana ayudaron a mezclar el cemento de la base. A través de ese telescopio vio por primera vez los anillos de Saturno y las lunas de Júpiter. Pero, en esa época, ni siquiera pensaba dedicarse a la ciencia. En su adolescencia eligió un colegio donde no enseñaban física ni química, solo por estar con sus amigas. Aun así, era muy buena en matemáticas. Por eso, más adelante, fue admitida en una universidad para estudiar ciencias. Aprendió desde cero, con esfuerzo y constancia, hasta convertirse en una de las científicas más importantes del Reino Unido.  Durante siglos, la ciencia fue un mundo cerrado para muchas personas. El cargo de Astrónomo Real se creó en 1675, cuando el rey Carlos II de Inglaterra inauguró el Observatorio Real de Greenwich. Desde entonces, 15 hombres lo habían ocupado. Nunca una mujer. Y mucho menos alguien que, de niña, no estudió ciencia en el colegio. Michele Dougherty rompió esa barrera, pero su propio deseo es que el reconocimiento no sea solo por ser mujer, sino por lo que ha logrado. Su trabajo en la sonda Cassini descubrió chorros de agua saliendo de Encelado, indicando actividad geológica y condiciones que podrían albergar vida. También lidera el magnetómetro de la misión JUICE, que va a estudiar Ganimedes, la luna más grande del sistema solar. Dougherty teme que la financiación de la ciencia se vea afectada por inestabilidad política y económica. Por eso, quiere usar este cargo para hablar con la gente sobre por qué la ciencia importa.  Como Astrónoma Real, Dougherty no manejará el observatorio ni trazará rutas marítimas usando las estrellas, como en el siglo XVII. El cargo se volvió honorífico desde 1972. Pero sí tendrá una función pública: inspirar, explicar, comunicar la importancia de la astronomía. “Quiero entusiasmar al público y hacerles ver que la astronomía afecta nuestra vida diaria”, dijo en una entrevista. Su nombramiento coincide con un cambio cultural en la ciencia británica. Desde 2021, Catherine Heymans ya ocupaba el cargo de Astrónoma Real de Escocia, y ahora ambas representan a todo el Reino Unido. Dougherty es también presidenta electa del Instituto de Física, profesora en Imperial College y presidenta del Consejo de Infraestructura Científica del Reino Unido. En todos esos roles, su mensaje es claro: la ciencia debe abrirse, debe explicarse, y debe entusiasmar a los niños y niñas que nunca se vieron a sí mismos como científicos.  La sonda Cassini, de la NASA, operó desde 1997 hasta 2017. Dougherty se unió al proyecto en 1992, como investigadora del instrumento de campo magnético. En 2005, notó una pequeña anomalía en los datos cuando Cassini sobrevoló Encelado. Insistió en volver a pasar cerca del polo sur de la luna, a pesar de las dudas de los líderes del proyecto. Y acertó: descubrieron un chorro de vapor de agua. Ese hallazgo cambió la visión que teníamos sobre las lunas heladas del sistema solar. Desde entonces, Encelado se considera uno de los lugares más prometedores para buscar vida. Ahora, su nuevo proyecto es JUICE, una misión de la Agencia Espacial Europea lanzada en 2023, que llegará a Júpiter en 2031. La nave estudiará si Ganimedes tiene un océano bajo su superficie. Dougherty diseñó el magnetómetro que viajará a bordo. La ciencia que lidera desde Londres está cambiando lo que sabemos sobre el sistema solar.  Michele Dougherty fue nombrada Astrónoma Real del Reino Unido, tras 350 años de historia masculina. Su trabajo sobre Encelado y Ganimedes transformó la exploración espacial.Sigue más historias como esta en el pódcast Flash Diario en Spotify.  Michele Dougherty, pionera en misiones a Saturno y Júpiter, es la primera Astrónoma Real en 350 años.

Imperial College's mathematical finance head introduces new tool to measure slippage and trade quality

Roshani Abbey is starring as Jean Leslie & Others in the West End production of Operation Mincemeat.Operation Mincemeat premiered on the London Fringe at the New Diorama Theatre in 2019. The show quickly gained a devoted following, and played sold out runs at Southwark Playhouse and Riverside Studios. The musical transferred to the West End in 2023, winning Best New Musical at the Olivier Awards. In addition to its London run, Operation Mincemeat is also playing on Broadway and will soon launch a world tour, opening in Salford next February.Roshani's theatre credits include: Tahlia the Beautiful in Sleeping Beauty (Broadway Theatre Catford), Soloist in Criterion Theatre 150th Anniversary Gala (Criterion Theatre), Marie in In Clay in Concert (The Other Palace), Lucy/cover Juliet in &Juliet (Shaftesbury Theatre), Rumi: The Musical (Concept album / London Coliseum) and Ensemble/cover Louise in Gypsy (Royal Exchange). She played Peggy/Maria in the West End production of Hamilton and went on to become a standby for all three Schuyler Sisters. Earlier this year Roshani returned to Hamilton to star as Eliza for a limited run on the UK & Ireland tour. In this episode Roshani discusses the whirlwind of joining Operation Mincemeat, their journey with the show so far and why it's such a special moment. Roshani also reflects on their path into theatre after studying Mathematics at Imperial College and talks about their history with Hamilton - and lots more pops up along the way!Operation Mincemeat runs in the West End at the Fortune Theatre. Meanwhile the show continues on Broadway and is about to launch a world tour. Visit www.operationmincemeat.com for info and tickets. This podcast is hosted by Andrew Tomlins @AndrewTomlins32 Thanks for listening! Email: andrew@westendframe.co.uk Visit westendframe.co.uk for more info about our podcasts. Hosted on Acast. See acast.com/privacy for more information.

Inchiesta sull’urbanistica a Milano: il Pd appoggia Sala ma con l’invito a dare "segnali di cambiamento”. Oggi il sindaco in Consiglio Comunale per ribadire la propria estraneità ai fatti e proseguire il mandato. Attese invece le dimissioni dell’assessore Tancredi. Sentiamo Sara Monaci de Il Sole 24 Ore. West Nile, una donna morta in provincia di Roma. Facciamo chiarezza con Andrea Crisanti, microbiologo, docente all’Imperial College di Londra, senatore Pd, autore di “Reazione genetica a catena. Capovolgere le regole dell'evoluzione” (Il Mulino).

What if you finally had a road map to your psychology?This week Alex shares a talk he gave at the MRC institute at Imperial College - Personality: How the Science of Who We Are Can Help Us Lead Better Lives.This talk describes how we can define personality, why its useful to have an understand of personality for career, relationships and quality of life, how personality affects our political leanings and much more. This lecture is also available on youtube:https://www.youtube.com/watch?v=4yI1EJfP1zgDr. Alex Curmi is a consultant psychiatrist and a UKCP registered psychotherapist in-training.Alex's TedX talk: https://www.youtube.com/watch?v=5JvG10zQups&t=52sIf you would like to invite Alex to speak at your organisation please email alexcurmitherapy@gmail.com with "Speaking Enquiry" in the subject line.Alex is not currently taking on new psychotherapy clients, if you are interested in working with Alex for focused behaviour change coaching , you can email - alexcurmitherapy@gmail.com with "Coaching" in the subject line.Check out The Thinking Mind Blog on Substack: https://open.substack.com/pub/thinkingmindblog/p/thinking-mind-blog-big-thoughts-edition?r=1cn09u&utm_medium=iosGive feedback here - thinkingmindpodcast@gmail.com Follow us here: Twitter @thinkingmindpod Instagram @thinkingmindpodcast

En el Consultorio de Bolsa con Javier Cabrera y Pepe Baynar, los expertos analizan la jornada bursátil y el sentimiento de mercado. Javier Cabrera, analista de mercados y Pepe Baynat, de Bolsas y Futuros, analizan los siguientes valores: Sobre Javier Cabrera Estudió ADE en la Universidad de Málaga. European Financial Advisor de la asociación EFPA. Certificado ESG Essential por EFFAS. Programa executive de Valoración de Empresas y Análisis Financiero por ISBIF. Curso de Especialización en Gestión de Carteras por AFI Escuela. Programa executive online de M&A por Imperial College. Datos relevantes: fundador y presidente del club de bolsa de la Universidad de Málaga. Sobre Pepe Baynat En Bolsas y Futuros somos muy dinámicos en las inversiones, por eso nos gusta hacer un seguimiento muy cercano y estar siempre ajustando los stops de pérdidas y convertirlos pronto en stops de beneficios. Operamos básicamente en valores que siguen nuestros criterios alcistas de largo plazo. Las entradas en los valores alcistas las hacemos con criterios de corto plazo. Aunque podemos permanecer meses en un mismo valor. No nos importa que se ejecuten los stops, porque la pérdida en un stop siempre es mucho más pequeña que los beneficios que obtenemos de las operaciones que salen bien. No nos importa volver a entrar en un valor que se acabe de ejecutar el stop, a un precio más caro, para nosotros cada operación es independiente de la anterior. Invertir en un valor bajista sin stop presenta varios problemas, el primero es que normalmente entraremos pronto en pérdidas y que éstas irán aumentando con el tiempo, y el segundo es el coste de oportunidad de no tener ese capital invertido en otro título que sí que esté dando buenos resultados. Los oyentes pueden mandarnos al Consultorio de Bolsa sus consultas a través de WhatsApp al teléfono 609 22 47 16. Si prefieren hablar directamente con los analistas y comentarles sus dudas, pueden contactarles en el número de teléfono 91 533 18 51.

In this episode, regional experts of the Middle East share their knowledge about Syria's healthcare system and how it has been affected by years of conflict. Based on research from the book "Everybody's War: Politics of Aid in the Syria Crisis," (published by Oxford University Press), our guests provide thoughtful analysis of several important issues:The connection between healthcare provision and questions of state legitimacyHow Syria's once-unified healthcare system became fragmented during the warThe complex dynamics of delivering humanitarian aid in a polarized conflict environmentThe discussion examines the practical and ethical challenges facing healthcare workers and aid organizations operating in contexts where corruption and restricted access are common.  The experts provide an informative overview for listeners interested in understanding the intersection of healthcare delivery, conflict, and humanitarian response in complex emergency settings.This episode offers valuable insights into how humanitarian assistance functions within the broader political and economic realities of the Syrian crisis.Omar Dewachi is associate professor at Rutgers University whose work is at the intersections of global health, history of medicine and political anthropology. His scholarship focuses on the human and environmental manifestations of decades of conflict and military interventions in Iraq and the broader Middle East. Duncan McLean is a senior researcher for Doctors Without Borders . He has published widely on the humanitarian sector and has contributed chapters to book publications Saving Lives and Staying Alive, The Politics of Fear, and Everybody's War. Dr. Mclean holds a PhD in history and has lectured at several universities in the Czech Republic, France and the UK, focusing on epidemiological and colonial history.Aula Abbara is a consultant in Infectious Diseases/ General Internal Medicine at Imperial College NHS Healthcare Trust, London and an Honorary Clinical Senior Lecturer at Imperial College. She teaches and supervises students on the Global Health BSc course at Imperial College and the TMIH at LSHTM. #Syria #Healthcare #HumanitarianCrisis #MiddleEast #ForeignAidSupport the showSupport the Center for Security, Race and Rights by following us and making a donation: Donate: https://give.rutgersfoundation.org/csrr-support/20046.html Follow us on Twitter: https://twitter.com/rucsrr Follow us on Instagram: https://instagram.com/rutgerscsrr Follow us on Threads: https://threads.com/rutgerscsrr Follow us on Facebook: https://facebook.com/rucsrr Follow us on TikTok: https://tiktok.com/rucsrr Subscribe to our Newsletter: https://csrr.rutgers.edu/newsroom/sign-up-for-newsletter/

The Prime Minister has launched a 'new era' for the NHS that aims to move away from reactive care in hospitals to preventing illness through community services. It's an ambitious plan and one with a lot of ambition and a lot of unknowns. James Gallagher discusses the plans with Sarah Woolnough, Chief Executive of The King's Fund, an independent think tank working to improve health and care across England, and Sally Gainsbury, Senior Policy Analyst at the Nuffield Trust, specialising in evidence-based research on health and social care provision in the UK.Artificial Intelligence (AI) is being touted as a way to improve efficiency and save money in the 10 Year Plan and every day in healthcare there are headlines about new AI-driven tools that could revolutionise medicine. In a new mini-series, James hears about different ways AI is being used starting with heart scans that use AI to analyse large amounts of data to predict health outcomes in a way that would be near impossible for a human to achieve. He talks to Dr Arunashis Sau from the National Heart & Lung Institute at Imperial College, London.Also, with a 200-year-old condom made from a sheep's insides attracting crowds to the Rijksmuseum in The Netherlands, James finds out about the history of condoms with cultural historian Dr Kate Stephenson.Presenter: James Gallagher Producer: Tom Bonnett Additional production: Ella Hubber Editors: Glyn Tansley and Martin Smith

Μια μελέτη-σταθμός από το Imperial College του Λονδίνου απέδωσε 1.500 θανάτους κατά τη διάρκεια του καύσωνα στην Ελλάδα και την νοτια Ευρώπη, την περασμένη εβδομάδα, απευθείας στην προκαλούμενη από τον συγχρονο πολιτισμό μας και τον ανθρώπινο παράγοντα κλιματική αλλαγή. Είναι η πρώτη μελέτη που συσχετίζει άμεσα και δεν συνδέει μόνο την κλιματική αλλαγή με τα καιρικά φαινόμενα, αλλά την συνδέει άμεσα με τους θανάτους ανθρώπων.

I'm beyond excited to share our latest podcast episode with you. This time, I had the pleasure of chatting with the incredible Maddi Holman, the general partner of Daring Ventures and the host of her own podcast, "Let's Be Heard." Maddi's journey from aspiring doctor to venture capitalist is nothing short of inspiring, and I can't wait for you to hear her story.Here are some of the key takeaways and intriguing insights from our conversation:

We look at the new book by Simon Horton. See more about The End of Conflict: How AI Will End War and Help Us Get On Better here. The End of Conflict:, How AI Will End War and Help Us Get On Better, reviewed We enjoyed reading this book. Initially we felt the title was counter intuitive, and it seems like the author also had thoughts, and doubts about this premise. Without giving away a plot spoiler it does that, by the end of the book, the author is not completely convinced himself either whether we can be completely confident about AI either. However, before we get to this slightly disconcerting ending the author does take us on a thoughtful, and provoking discussion of some potential positive benefits that could come from AI. Horton discusses how AI could help with conflict resolution, including for couples. While you can imagine the initial skepticism he does a good job of explaining how and why it might work, and could, quite quickly become adopted and used subsequently. As with all things, if you can get to trying it once, and this has positive results, people are quite likely to then return again and again, with even better outcomes. Horton is aware that things could all go pear shaped too when it comes to AI and the future of humanity too. While he explores and explains in a convincing way the paths that could lead to better outcomes, he also accepts that this is not a sure thing, and that we do live in risky times. This is probably a fair way to treat the options in front of us. A well written book, worth reading and following Horton's exploration of these challenging times. See more about the book here The end of conflict? Sounds impossible, like the lion lying down with the lamb. But what if it were achievable? World-renowned Negotiation expert Simon Horton has spent 25 years working with the British Army, hostage negotiators and some of the biggest companies in the world. He has also spent 20 years studying artificial intelligence and he reveals how the rapidly growing field of Peace Tech really could end war, heal our polarised societies, and improve our closest relationships. Humans know how to resolve conflict in theory but, in practice, our egos and emotions get in the way. AI has no such limitations. With its ability to manage vast datasets and develop creative solutions to seemingly intractable problems, AI could transform how we handle disagreements at every level. There's a catch, of course. Can we trust the AI? Can we trust the tech companies? Including interviews with Professor Steven Pinker, Bruce Schneier and many similar experts in their field, "The End of Conflict" builds a plausible roadmap to the optimistic future of the title and shows what we must do to ensure everyone benefits fairly from these powerful new technologies. More about the author Simon Horton is the founder of Negotiation Mastery, a centre of excellence in the world of negotiation. His mother was Irish Catholic and his father English Protestant. He grew up in the 1970s and every time there was a bomb in Northern Ireland, the civil war was fought at his dining table. Even at the age of 10, he knew there was a better way. He has been teaching negotiation and conflict resolution for 20 years, across 25 different countries. Clients have included Goldman Sachs, HM British Army, the Saudi Space Agency and many similar world class organisations. He has taught at Oxford University and Imperial College and has appeared on national television in multiple countries and is regularly interviewed on the topic in national press and magazines. Prior to teaching negotiation, he led a successful career as a consultant to the financial services sector, designing derivatives trading systems and similar platforms. He was first involved with AI in 1988 and his interest grew with Moore's Law. By 2005, and the publication of Ray Kurzweil's "The Singularity Is Near", he had become obsessed. He has performed as a stand-up comedian and a trapeze artist and h...

Today's episode features guest host Michael Upshall (guest editor, Charleston Briefings) who talks with Stephen Webster, Director, Science Communication Unit, Imperial College, London. Stephan began his career by studying biology and the life sciences and attended Cambridge University where he studied the philosophy of science, and became interested in how science is understood and taught. He spent several years as a secondary school science teacher in London and eventually led one of the first science communication master's programs, and is currently a senior lecturer at Imperial College. Stephen believes that engaging and listening to the public is very important with science communication to build trust, and to see the public as partners who could be very knowledgeable. He also says that good science is built on well-supported scientists.  The video of this interview can be found here: https://youtu.be/yG6kJtvfx7A Social Media: LinkedIn: https://www.linkedin.com/in/mupshall/ https://www.linkedin.com/in/stephen-webster-36723853/ Twitter: Keywords: #SciComm, #ScienceCommunication #PublicEngagement #ScienceEducation #HigherEducation #OpenScience #ResearchCulture #EthicsInScience #CommunityEngagement #LibraryInnovation #Innovation #LibraryJobs #career #collaboration #scholcomm #ScholarlyCommunication #libraries #librarianship #LibraryNeeds #LibraryLove #ScholarlyPublishing #AcademicPublishing #publishing #LibrariesAndPublishers #podcasts

Nouvelle diffusion du 21 septembre 2024 Une vie à percer les mystères de la gravitation : Claudia de Rham partage son parcours scientifique et ses recherches. La Lausannoise, aujourdʹhui professeure à lʹImperial College de Londres, raconte son histoire dans La beauté de la chute (éditions Quanto). Quelle place pour les femmes dans la formation scientifique aujourdʹhui ? Karine Vasarino a interrogé deux étudiantes qui ont choisi cette voie.

Científicos británicos crean genes humanos en laboratorio para estudiar enfermedades y desarrollar terapias celulares del futuro  Por Félix Riaño @LocutorCo   Investigadores del Reino Unido están construyendo fragmentos de ADN humano sintético para entender cómo funciona el genoma y diseñar nuevos tratamientos.  Un equipo de científicas y científicos del Reino Unido está comenzando un experimento tan ambicioso como polémico: fabricar partes del ADN humano desde cero. Es decir, no editar genes existentes, sino construir nuevas cadenas genéticas, base por base, como si estuvieran armando un genoma humano desde el principio.El proyecto se llama Synthetic Human Genome, o SynHG, y su objetivo es comprender cómo funciona el ADN para poder crear terapias más precisas y resistentes a enfermedades.Con una inversión inicial de 10 millones de libras esterlinas por parte de la fundación médica Wellcome Trust, el proyecto reúne a expertos de universidades como Cambridge, Oxford e Imperial College.Van a dedicar cinco años a crear herramientas para ensamblar secciones grandes de un cromosoma humano en el laboratorio y observar cómo se comportan en células vivas. Pero no todo es esperanza médica: también hay preguntas éticas difíciles. ¿Qué pasa si alguien usa esta tecnología para crear armas biológicas o humanos modificados?  La promesa médica es enorme, pero el debate ético ya está encendido.  Desde que se completó el Proyecto Genoma Humano en 2003, los científicos han logrado leer el ADN como si fuera un código de barras.Pero leer no es lo mismo que escribir.Ahora, el objetivo del SynHG es ir más allá y construir fragmentos del genoma humano como prueba de concepto. El primer paso será crear un cromosoma sintético, que representa aproximadamente el dos por ciento del ADN humano total. Para lograrlo, están utilizando inteligencia artificial y tecnologías de ensamblaje molecular, con la idea de diseñar células humanas que funcionen igual que las naturales, pero con mejoras específicas.Por ejemplo, células que puedan resistir virus o regenerar órganos dañados como el hígado, el corazón o incluso el sistema inmunológico. Aunque hoy suena a ciencia ficción, el equipo ya logró sintetizar el genoma completo de bacterias como E. coli, así que el reto ahora es escalar esa tecnología a un nivel humano. Y si lo logran, podríamos estar frente al inicio de una nueva medicina.  Este avance tecnológico trae consigo un debate ético urgente y profundo. El solo hecho de poder fabricar cromosomas humanos en laboratorio plantea preguntas como: ¿Quién tendrá el control de estas tecnologías? ¿Qué uso se les dará? ¿Cómo se va a regular su aplicación?Algunas voces ya advierten que los riesgos van más allá de los laboratorios. Por ejemplo, el profesor Bill Earnshaw, de la Universidad de Edimburgo, señaló que si un grupo con malas intenciones accede a esta tecnología, podría sintetizar organismos para crear armas biológicas o alterar el equilibrio ambiental. Y hay otra preocupación: la creación de “bebés a la carta”.  Aunque los investigadores insisten en que eso no es el objetivo, temen que en el futuro alguien intente copiar el ADN de celebridades o modificar genes para diseñar seres humanos a medida.También hay un dilema legal: si se crean tejidos, células u órganos sintéticos, ¿quién será el dueño ¿El laboratorio, el paciente, o la empresa que fabrica las herramientas?Por eso, el proyecto incluye desde el comienzo un componente social y ético llamado Care-full Synthesis, liderado por la profesora Joy Zhang. Este programa está trabajando con comunidades de todo el mundo para debatir abiertamente los límites, los miedos y los beneficios de esta nueva etapa de la biología.  El futuro que propone el proyecto SynHG es tan fascinante como complejo. En el mejor de los casos, podríamos tener terapias celulares que no provoquen rechazos, tejidos inmunes a enfermedades como el cáncer o el VIH, y órganos cultivados a partir de células sintéticas para trasplantes. También se podrían evitar enfermedades hereditarias graves, como las mitocondriales, sin necesidad de recurrir a donantes. La posibilidad de diseñar mitocondrias sintéticas, por ejemplo, reduciría a la mitad el número de mujeres que deben someterse a procesos invasivos para evitar transmitir estas condiciones a sus hijas o hijos.A nivel científico, esta tecnología permitiría probar hipótesis sobre la función del genoma, algo que hoy solo se puede hacer modificando genes existentes. Por ejemplo, entender partes del genoma que se conocen como “materia oscura genética”, que aún no sabemos para qué sirven. Pero hay una condición importante: la investigación debe ser abierta, responsable y equitativa. Actualmente, la mayoría de los estudios genéticos se concentran en personas de ascendencia europea.El programa Care-full Synthesis busca corregir este sesgo e involucrar a comunidades de América Latina, África y Asia, para que sus perspectivas también definan cómo debe usarse esta tecnología.Construir un genoma humano completo podría tardar décadas, pero el solo hecho de crear un cromosoma ya sería un hito que cambiaría nuestra comprensión de la vida.  El ADN humano está formado por más de 3.000 millones de pares de bases, mientras que el genoma de bacterias como Mycoplasma genitalium o E. colitiene apenas entre 500.000 y 4.500.000.Esa diferencia de complejidad muestra por qué este proyecto es tan ambicioso. El director de investigación del Wellcome Trust, Michael Dunn, dijo que entender el genoma a través de la síntesis genética puede ayudarnos a responder preguntas sobre salud y enfermedades que hoy ni siquiera sabemos formular.Y no se trata solo de medicina. También podría usarse para mejorar cultivos agrícolas resistentes a plagas y al cambio climático. En ese sentido, la biología sintética no es solo una herramienta médica, sino también una estrategia para enfrentar desafíos globales. Aún no hay terapias listas para usar, pero este es el momento ideal para hablar de sus límites. El pasado nos ha enseñado que es mejor desarrollar estas tecnologías con reglas claras desde el comienzo, que intentar corregir los errores después. Por eso, científicos, sociólogos, organizaciones civiles y gobiernos están invitados a participar desde ya en el debate. Lo que está en juego no es solo un avance científico. Es decidir juntos qué tipo de futuro queremos construir.  El proyecto SynHG busca fabricar fragmentos de ADN humano desde cero para diseñar nuevos tratamientos. ¿Será el comienzo de una nueva era biológica? Sígueme en Flash Diario en Spotify para descubrirlo cada día.  Crean ADN humano en laboratorio desde cero. ¿Será la cura del futuro o un riesgo global? La ciencia da otro paso.  

Market Musings with Patrick Cheetham MD Sunrise Resources  Patrick Cheetham, of Sunrise Resources, joins the Market Musings Podcast to talk about his journey from teenage rock collector to leading exploration companies. Discover how he started Dragon Mining at age 26, survived market crashes and why industrial minerals are now his focus.  

Ter pesadelos com frequência é indicador de risco de morte prematura. Estudo do Imperial College de Londres feito com adultos e crianças.

We are surrounded by bold claims and quick fixes for ‘boosting' our immune health. But one thing the science is clear on is that everyone's immune system is unique – what is good for one person may not work well for another. So how do we separate the bogus claims from the useful advice? Head of Life Sciences and Professor of Immunology at Imperial College, Daniel Davis, helps us sort the facts from the fiction. From the genetics of immune health to the myth of Vitamin C, from evidence-backed studies on chronic stress to the gaps in knowledge on sleep and microbiome health, Daniel reveals what scientists do know for certain—and what still needs more answers—to help us make informed choices for ourselves. Learn more about your ad choices. Visit podcastchoices.com/adchoices

En el Radar Empresarial de hoy analizamos la quiebra de Builder AI, la startup de Inteligencia Artificial que ha logrado engañar entre otros a Microsoft o al fondo soberano de Qatar. La compañía se declara en bancarrota después de solo nueve años de vida. En 2016, Sachin  Dev  Duggal y Saurabh  Dhoot se conocen en el Imperial College de Londres y tienen una idea: los dos ingenieros pretendían repartir software bajo demanda a los clientes usando inteligencia artificial para crear el código que sería la base de sus productos. Bajo esta premisa, pronto empezaron las rondas de financiación. En 2019, las compañías Lakestar y Jungle Ventures le dieron 29 millones de dólares. En 2022, Insight Partners invirtió en la startup 100 millones. Aunque la más importante llegaría solo un año después. En 2023, la empresa consiguió más de 450 millones entre el fondo soberano de Qatar y Microsoft, que se alió con la empresa para sacar la herramienta Builder AI. Y es que las rondas de financiación aparecían a la vez que los problemas. Ya en 2019, The Wall Street Journal alertaba que la compañía en realidad no usaba inteligencia artificial para desarrollar sus productos. Ese mismo año, un ex empleado, Robert Holdheim, denunció a la compañía ya que aseguraba que la empresa “publicitaba unos productos que no eran en realidad los usados”. De forma sorprendente, estas informaciones no hicieron decaer la confianza en los inversores. De hecho, en 2024 una ronda de financiación liderada por la empresa isrealí hizo que la empresa se valorara en 1500 millones de dólares. Parecía que la empresa sorteaba todas las informaciones aunque nada más lejos de la realidad. A principios de este año el Financial Times informó que el CEO de Builder AI, Sachin Dev Duggal, estaba siendo investigado en la India por conductas delictivas. Duggal, acorralado entre las informaciones de fraude y unido a estas últimas publicaciones no tuvo más remedio que dimitir. Aunque contrario a lo que se esperaba, no desapareció de la escena pública. De hecho, hace tres semanas, declaró en el Mobile World Congress de Barcelona que se mostraba muy optimista con el futuro de la IA. Un optimismo que no ha llegado al final para la compañía. A pesar de que en marzo asumió el cargo como CEO Manpreet Ratia, el destino de la compañía estaba sellado. La petición de Visa Credit de tomar los fondos que había invertido supuso el golpe final. ¿Pero cómo logró engañar una pequeña empresa a los grandes gigantes del mercado? Con solo 700 empleados en la India, según Bloomberg la compañía usó la táctica conocida como “viaje de ida y vuelta”: Dos empresas emiten facturas la una a la otra por trabajos que, en realidad, no se llevan a cabo. Esta práctica la llevó a cabo con la red social VerSe Innovation.

Dr Charlie Andrews talks to Dr James Kinross, PhD, FRCS Dr. Kinross is a senior lecturer in surgery at Imperial College in London. He is also a practicing colorectal surgeon in the NHS with a clinical interest in the prevention and treatment of colon cancer. He leads a team of amazing researchers working to better define how the microbiome causes cancer and other chronic diseases of the gut. He is increasingly interested in how the gut microbiome develops in newborn babies and the implications on our long-term health. He is the author of the well know book DARK MATTER.Here are the key learnings for primary care on the microbiome from the attached transcript of the Ingest podcast with James Kinross:Key Learnings for Primary Care on the Microbiome1. What the Microbiome Is and Why It MattersDefinition: The microbiome is the collection of all microscopic organisms (bacteria, viruses, fungi, etc.) and the environment they inhabit within a specific niche in the body, such as the gut, skin, or lungs. Symbiosis: The microbiome has a symbiotic relationship with the host, evolved over millennia. It is not static but dynamic and changes throughout life. Personalization: Each person's microbiome is unique, impacting how individuals respond to treatments and develop diseases[1].2. Microbiome Development and Early LifeEarly Colonization: The microbiome starts developing in utero, influenced by the mother's microbiome, and is further shaped by birth route, breastfeeding, and early environmental exposures. Critical Window: Early life is a critical period for microbiome development. Disruption, especially through antibiotic use, can have long-term effects on immune system development and disease risk[1]. Antibiotics Impact: Repeated or broad-spectrum antibiotic use in early life can lead to persistent changes in the microbiome, increasing the risk of immune-mediated diseases (e.g., allergies, asthma, eczema), obesity, and other non-communicable diseases[1].3. Microbiome and the Immune SystemImmune Regulation: The microbiome plays a crucial role in shaping both the innate and adaptive immune systems. It influences how the body recognizes and responds to threats. Disease Risk: Early disruption of the microbiome can increase susceptibility to autoimmune diseases, allergies, and chronic conditions later in life. Gene-Environment-Microbiome Interaction: Disease risk is not just about genes and environment but also involves the microbiome (GEM interaction), which is highly personalized and dynamic[1].4. Probiotics, Prebiotics, and DietProbiotics: There is evidence supporting the use of probiotics, especially multi-strain, high-dose formulations, during and after antibiotic courses. However, probiotics must be taken consistently for weeks to have an effect. Prebiotics and Diet: Feeding the microbiome with a high-fiber, plant-based diet is crucial for maintaining a healthy gut ecosystem. Processed foods and sugary drinks should be minimized, especially during illness or antibiotic treatment[1]. Practical Advice: Clinicians should recommend probiotics and dietary changes as part of a holistic approach to gut health, but the evidence for specific strains is still evolving[1].5. Microbiome TestingDirect-to-Consumer Testing: Online microbiome tests are not currently recommended due to lack of stand... Chapters (00:00:00) - Ingest: The microbiome(00:01:06) - Dark Matter(00:03:45) - What exactly is the microbiome?(00:06:11) - What is the microbiome?(00:08:49) - The role of the microbiome in health(00:09:54) - Antimicrobial agents in the gut(00:13:20) - Probiotics and antibiotics(00:15:37) - How the microbiome affects the immune system(00:24:05) - The role of the microbiome in health(00:27:04) - Will we measure the microbiome 100%?(00:31:02) - Primary care: The microbiome challenge(00:32:22) - Probiotics and the future of gut health(00:36:02) - The microbiome of the human gut

In this episode of The Digital Marketing Podcast, Daniel, Ciaran, and Louise take a deep dive into the often-misunderstood world of keyword research - one of the most foundational yet complex elements of digital marketing. What starts as a seemingly simple task (“just pick some keywords, right?”) quickly unravels into a minefield of audience intent, brand positioning, search behaviour shifts, and the sometimes soul-crushing reality of traffic that doesn't convert. The trio break down the full process with real-world insight, humour, and some very candid reflections on what not to do. From teaching postgraduate students at Imperial College to running real commercial SEO campaigns, Daniel shares his evolving approach to keyword strategy - highlighting how brand clarity, buyer personas, and mapping the full user journey are essential to getting keyword research right. What you'll learn in this episode: Why volume-based keyword selection is a trap How to balance traffic, intent, and competition in your keyword choices Why middle-of-the-funnel content is often your secret weapon How to prune and optimise your existing content for better conversions The problem with vanity metrics (and what to track instead) How new AI-powered tools like Content Raptor and Keywords Everywhere are changing the game The role of search across Google, YouTube, social and even email What to look for in competitor analysis and how to use keyword clustering effectively Louise brings sharp insight into modern search behaviour and the growing importance of voice, conversational search, and featured snippets, while Ciaran opens up about years of chasing traffic volume before realising conversions are what truly count. (Spoiler: a blog about banana peels and Botox might bring in traffic—but probably not sales.) The episode ends with a step-by-step process for approaching keyword research in 2025, including content ideation, testing, SEO hooks, and how to integrate what you learn across multiple marketing channels. Key Takeaways: Keyword research isn't about finding more keywords - it's about finding the right ones. Strategic alignment between brand, content, and intent is critical. Most marketers overinvest in top-of-funnel traffic and neglect conversion-focused content. Updating and optimising your existing content can often move the needle more than publishing something new. A good keyword is one that drives results - not just visits. With tools, frameworks, and honest advice, this episode is your ultimate keyword research sanity-check. Whether you're building a content strategy from scratch or refining an existing one, this is the guide you didn't know you needed.

Melvyn Bragg and guests discuss the decisive role of one of the great 20th Century physicists in solving the question of nuclear fission. It is said that Meitner (1878-1968) made this breakthrough over Christmas 1938 while she was sitting on a log in Sweden during a snowy walk with her nephew Otto Frisch (1904-79). Both were Jewish-Austrian refugees who had only recently escaped from Nazi Germany. Others had already broken uranium into the smaller atom barium, but could not explain what they found; was the larger atom bursting, or the smaller atom being chipped off or was something else happening? They turned to Meitner. She, with Frisch, deduced the nucleus really was splitting like a drop of water into a dumbbell shape, with the electrical charges at each end forcing the divide, something previously thought impossible, and they named this ‘fission'. This was a crucial breakthrough for which Meitner was eventually widely recognised if not at first.WithJess Wade A Royal Society University Research Fellow and Lecturer in Functional Materials at Imperial College, LondonFrank Close Professor Emeritus of Theoretical Physics and Fellow Emeritus at Exeter College, University of OxfordAnd Steven Bramwell Director of the London Centre for Nanotechnology and Professor of Physics at University College LondonProducer: Simon TillotsonReading list:Frank Close, Destroyer of Worlds: The Deep History of the Nuclear Age, 1895-1965 (Allen Lane, 2025)Ruth Lewin Sime, Lise Meitner: A Life in Physics (University of California Press, 1996)Marissa Moss, The Woman Who Split the Atom: The Life of Lise Meitner (Abrams Books, 2022)Patricia Rife, Lise Meitner and the Dawn of the Nuclear Age (Birkhauser Verlag, 1999) In Our Time is a BBC Studios Audio Production

For EP31 of Chain Reactions, we sat down with Bettina Sosa — one of the newest guild leads at Myosin and our DevRel whisperer — to unpack why every founder building in crypto needs to treat Developer Relations as a core part of their go-to-market motion.We trace Bettina's path from researching self-sovereign identity at Imperial College (shoutout to her Venezuelan roots and her early hopes to fix broken ID systems) to helping major DAOs like Aragon and Bankless with their onboarding UX. Along the way, she shares what it was like moving from research to shipping product, how she started writing dev-focused content to demystify EVM and MEV, and why so much DevRel in Web3 misses the mark.We go deep on what great DevRel actually looks like — beyond just hackathons and bounties — and explore everything from niche TG groups and cold outreach to AI learning tools, dev onboarding trends, and the regions everyone's sleeping on (spoiler: it's not just Asia anymore).If you're serious about growing your protocol, building developer ecosystems, or just want to understand why “just having docs” won't cut it — this one's for you.Please enjoy, and as always, don't forget to subscribe, give us a five-star review, and mint the episode at pods.media/myosinxyz!

Have you ever wondered how much of your success is down to luck? What if the world is far less fair and predictable than we'd like to think? On this episode, I explore the complex and fascinating role of luck in our lives and decisions with Dr. Chengwei Liu, Associate Professor of Strategy and Behavioural Science at Imperial College London. Chengwei shares how his research challenges our assumptions about skill, effort, and fairness – and why the outcomes we see are often far more random than we'd like to believe. We discuss why many successful strategies and best practices are built on shaky ground, and how our tendency to downplay luck creates illusions of control and reinforces unfair systems. Chengwei explains how beliefs in fairness – like the ‘just world' hypothesis – shape everything from business cultures to political systems, and how luck and misperceptions of it can create cycles of privilege or disadvantage. Chengwei also shares practical insights on how to become a smart contrarian: someone who can harness the power of randomness and serendipity while avoiding the pitfalls of bias and overconfidence. From the dangers of blindly following the ‘successful' to the need to look inward and embrace uniqueness, it's a thought-provoking conversation that will change the way you think about risk, decision-making, and what it really means to get ahead. Guest BiographyDr. Chengwei Liu is an Associate Professor of Strategy and Behavioural Science at Imperial College London. He describes himself as someone fascinated by how luck, randomness, and human biases shape success and failure – both in business and in broader society. Chengwei's work challenges mainstream management thinking and explores how much of what we attribute to skill is actually the result of random factors. His book, Luck: A Key Idea for Business and Society, examines these dynamics and how we can learn to navigate them. Beyond his academic roles, Chengwei has also worked as a management consultant, drawing on his experience in both research and practice to uncover how to harness luck and uncertainty. AI-Generated Timestamped Summary[00:00:00] Introduction[00:02:00] Chengwei explains his research focus on randomness and variance in firm performance [00:04:00] The overlooked 50% of variance in outcomes: luck and randomness [00:06:00] Defining luck as what lies beyond our control and foresight [00:08:00] The conflict between fairness beliefs and the reality of luck [00:10:00] Luck's societal implications: why fairness perceptions differ across countries [00:11:00] Skill versus luck – how we confuse the two in our narratives [00:13:00] Why successful people over-attribute their success to skill [00:15:00] Managers vs entrepreneurs: how they differ in acknowledging luck [00:17:00] The challenges of researching an elusive concept like luck [00:18:00] Using mathematical models to understand Black Swan events [00:20:00] Why successful predictions of Black Swan events don't indicate forecasting skill [00:23:00] The problem with best practices from ‘successful' firms [00:26:00] Selection bias in business books and the danger of survivor bias [00:29:00] The ‘too good to be true' heuristic as a guide [00:31:00] Contrarian thinking as a survival strategy for uncertainty [00:33:00] The replication crisis and the problem with social science predictability [00:35:00] Human curiosity: the power of moderate surprises [00:37:00] The difference between luck and serendipity [00:39:00] How to encourage serendipity in our lives [00:41:00] Embracing uniqueness and avoiding conformity [00:44:00] Lessons for the age of AI and human creativity [00:46:00] The dangers of ignoring randomness: when biases become destructive [00:48:00] Exploiting others' biases for strategic advantage [00:50:00] Why ‘smart contrarian' thinking is more important than ever [00:53:00] Testing contrarian ideas like a scientist [00:56:00] The limits of trial and error: learning from mistakes [00:58:00] Chengwei's ongoing research: minority decision-making in venture capital [01:00:00] How passion and variance link to VC investment strategies [01:02:00] Wrapping up with reflections on luck, curiosity, and human creativity LinksDr. Chengwei Liu's book, Luck: A Key Idea for Business and Society: https://www.routledge.com/Luck-A-Key-Idea-for-Business-and-Society/Liu/p/book/9781138094260? Chengwei Liu's Imperial College faculty webpage: https://profiles.imperial.ac.uk/c.liu

Em cooperação com a Fiocruz, pesquisadores do Imperial College de Londres estudam como replicar no sistema de saúde britânico, o NHS, o serviço oferecido no Brasil pelos agentes comunitários de saúde. Neste episódio do DW Revista, conversamos com a repórter Alice de Souza, que vive no Reino Unido e conta por que essa metodologia brasileira chamou a atenção e como é a cooperação entre os países.

The Textile Innovation Podcast speaks with Stephen Bates, CEO of Rheon Labs. RHEON is a dynamic material that is naturally soft and flexible - it absorbs ultra-high levels of energy by stiffening when subject to force. UK-based company Rheon Labs creates the material, which was born out of NASA and developed at Imperial College in London. In this episode CEO Stephen Bates explains how the material has been developed, its impact and how it has been integrated in the textile and apparel industry. Bates describes how the material has been used in the sportswear sector, for example in sports bras. Rheon also worked on Adidas's sports kits for team GB, France and Ethiopia for the Paris 2024 Olympics - it featured on the legs, backs and busts. Within this episode, Bates further delves into the material's potential in the sportswear category.He also touches upon cross sector collaboration and the other sectors where we could see the material feature. To learn more please visit rheonlabs.com.You can listen to the episode above, or via Spotify and Apple Podcasts. To discuss any of our topics, get in touch by following and connecting with WTiN in LinkedIn, or email aturner@wtin.com directly. To explore sponsorship opportunities, please email sales@wtin.com.

Today's episode features guest host, Michael Upshall, Consultant, ConsultMU Ltd., who talks with Torsten Reimer, Dean, University Library, University of Chicago. Torsten currently oversees one of the world's largest academic library collections. In this conversation, Torsten shares his diverse academic journey which began as a historian with a focus on British maritime history,  before leading various digital and research initiatives at King's College in London, JISC, the Imperial College in London and the British Library, and then to the University of Chicago where he leads the UChicago Node initiative, which is an integrated digital collections platform. Torsten says libraries play a very important role in the global research and knowledge ecosystem, in facilitating collaboration, and that they have an evolving role in the digital age ensuring digital content is preserved for future use.  The video of this interview can be found here: https://youtu.be/mSb_jwiDY7Y Social Media: LinkedIn: https://www.linkedin.com/in/mupshall/ https://www.linkedin.com/in/torstenreimer/ Keywords:#InformationPower #knowledge #awareness #innovation #skills #FutureOfLibraries #InclusiveEducation #career #partnerships #collaboration #scholcomm #ScholarlyCommunication #libraries #librarianship #LibraryNeeds #LibraryLove #ScholarlyPublishing #AcademicPublishing #publishing #LibrariesAndPublishers #podcasts

Veja o vídeo completo em expresso.pt/podcasts/45-graus António Costa Silva é engenheiro, professor universitário aposentado e gestor. Nasceu em Angola, formou-se no Instituto Superior Técnico, em Lisboa, e estudou no Imperial College, em Londres. Tem uma longa carreira ligada ao setor da energia. Em 2020, foi convidado pelo Governo para preparar a Visão Estratégica para o Plano de Recuperação Económica de Portugal 2020-2030. Entre 2022 e 2024 foi Ministro da Economia e do Mar do XXIII Governo Constitucional. _______________ Índice: (0:00) Introdução (4:34) Livro Governar no Século XXI e as reformas urgentes na Administração Pública | Tutelas partilhadas | ‘Síndrome do bom aluno’ | O medo de decidir (21:07) De onde vem a aversão ao risco e a decidir na nossa AP? | Ideia de eventos internos anuais para planeamento estratégico (29:22) É possível definir no Estado objetivos (KPIs), como nas empresas? (32:34) Problema do nosso baixo capital social | Agendas Mobilizadoras (37:23) Instabilidade dos governos e ignorância dos ministros (44:10) A nossa AP tem capacidade para implementar o PRR? | Estudo do BdP | Agendas Mobilizadoras | Digitalizar a AP (50:35) Onde estão as bolsas de excelência na AP? Quais são as causas? (58:20) Excesso de foco dos governos no curto-prazo | Adm Publica em Singapura | Excesso de ímpeto legislativo dos governos (1:08:56) Como foi ser um independente no governo? (1:11:09) Como é a relação de um ministro com os directores-gerais da AP? | “A ambiguidade (na decisão) mata.” | A politização dos gabinetes ministeriais (1:20:20) De onde vem a nossa atração por líderes autoritários, mesmo à esquerda? (1:24:59) O que se passa com o Banco de Fomento?See omnystudio.com/listener for privacy information.

In this insightful episode, consultant child and adolescent psychiatrist Dr Vic Chapman joins us to explore anorexia nervosa — a complex and often misunderstood eating disorder that affects many young people. Dr Chapman explains the key features of anorexia nervosa, early signs, the psychological and physical impacts, the diagnostic process, and wholistic treatment approaches. She also discusses the importance of early identification and timely intervention, the role of family-based support, and the multifaceted factors that lead to recovery. We also hear from a young expert-by-experience who bravely shares her personal journey with anorexia nervosa. Now in recovery, she reflects on the realities of experiencing anorexia nervosa, the support that made a difference, and what helped them move toward healing. her story brings a powerful and hopeful perspective to the conversation. Last but not least, Professor Dasha Nicholls, an academic child and adolescent psychiatrist at Imperial College, National Specialist Advisor on Eating Disorders, NHS England and RCPsych's Clinical & Strategic Director, National Audits & Research, provides an overview of the latest research and policy developments in the field. She highlights the growing emphasis on personalised care through identifying individual risk factors, and how eating disorders in young people remain a national healthcare priority. Her insights shed light on the future direction of eating disorder care - and highlight the critical role of digitalisation of services and routinely collected clinical data in advancing accessible, tailored support. LINKS: https://www.rcpsych.ac.uk/mental-health/order-mental-health-resources https://www.beateatingdisorders.org.uk/

In this episode of THE MENTORS RADIO, host Tom Loarie talks with Justin Stebbing, M.D., a London-based, world-renown scientist, cancer researcher, medical journal editor and author. Dr. Stebbing talks about the excitement and rewards of a STEM career, the life of a scientist, and about his own journey to becoming a world-renown clinician and scientist. He also about the tremendous wonder of discovering improved therapies for cancer and for treating covid. Professor Justin Stebbing, M.D., is also a professor of biomedical sciences at ARU, Cambridge, and a visiting professor at Imperial College where he has an active and widely known translational laboratory. He is the author of more than 700 peer-reviewed papers published in The Lancet, The New England Journal of Medicine and elsewhere. Dr. Stebbing is the co-chief editor of Oncogene and author of the book, Witness to Covid. Find Show Notes below. Listen to this episode below and on ANY podcast platform (from Apple to Spotify, Google, Stitcher, Spotify, TuneIn, etc) by typing in “THE MENTORS RADIO” … even easier, Subscribe HERE to listen on any podcast platform!!! SHOW NOTES: JUSTIN STEBBING, M.D.: BIO: https://www.imperial.ac.uk/people/j.stebbing AND https://justinstebbing.me/ BOOK: Witness to Covid: The diary of a global pandemic, by Professor Justin Stebbing ARTICLES: PROFESSOR JUSTIN STEBBING: The revolution that makes me believe we really CAN beat cancer in my lifetime

Ambitious climate policies may overlook practical constraints. Kleinman Center Visiting Scholar Niall Mac Dowell explores what deliverable paths to net zero might require. --- The Earth’s average temperature surpassed the 1.5°C threshold for the first time in 2024—a milestone driven in part by El Niño, but also a stark warning about our broader climate trajectory. While temperatures may moderate slightly in 2025, the world remains far from taking the decisive action needed to avoid the most severe impacts of climate change. The obstacles to meaningful progress are complex, spanning economics, politics at local and global levels, and questions of technological scalability. The good news is that these are solvable challenges. Yet, despite our collective capacity, we’ve struggled to overcome the headwinds that continue to slow decisive climate action. On the podcast, Niall Mac Dowell, visiting scholar at the Kleinman Center and professor of Future Energy Systems at Imperial College London, takes stock of where we are now. His work focuses on the transition to a low-carbon economy, with recent research exploring the feasibility of clean energy development projections and the role negative emissions could play in achieving net-zero goals. He shares his perspective on what it will take to move more decisively toward a sustainable energy future. Niall Mac Dowell is Professor of Future Energy Systems at Imperial College London. Related Content Has Europe’s Emissions Trading Scheme Taken Away a Country’s Ability to Reduce Emissions? https://kleinmanenergy.upenn.edu/research/publications/has-europes-emissions-trading-scheme-taken-away-a-countrys-ability-to-reduce-emissions/ Closing the Climate Finance Gap: A Proposal for a New Green Investment Protocol https://kleinmanenergy.upenn.edu/research/publications/closing-the-climate-finance-gap-a-proposal-for-a-new-green-investment-protocol/ Climate Action in the Age of Great Power Rivalry: What Geopolitics Means for Climate https://kleinmanenergy.upenn.edu/research/publications/climate-action-in-the-age-of-great-power-rivalry-what-geopolitics-means-for-the-climate/ Energy Policy Now is produced by The Kleinman Center for Energy Policy at the University of Pennsylvania. For all things energy policy, visit kleinmanenergy.upenn.eduSee omnystudio.com/listener for privacy information.

In this episode, our guest is Jonathan Haskel from Imperial College and we talked about productivity puzzle in the UK, general productivity slowdown, intangible capital, and finance! Current Host: Ruveyda Gozen (@ruveyda_gozen)04:00 Productivity Puzzle in the UK 11:12 Productivity Slowdown and Intangible Capital29:25 Finance and Intangible Capital Investment35:34 Some “personal” questions!41:53 Game on! This or That? 

To mark the start of flea season we bring you this classic episode from the archive. Vet and Environmental campaigner, Andrew Prentis is also  a ‘fellow' at Imperial College. He is amongst the team of scientists that have advised pet owners to be more sparing in their use of toxic flea and tic treatments, warning that they are entering watercourses and damage aquatic ecosystems. Reviewing 160 scientific papers on the impact on aquatic ecosystems of imidacloprid, a pesticide used in 138 pet treatments sold in the UK. They found that “one monthly flea treatment for a large dog contains enough imidacloprid to kill 25 million bees".   In the decade up to 2019, the sale of the pesticide for veterinary use in the UK increased 152 per cent. In that year, 2,500kg of the substance were sold for veterinary use, not much less than the 4,000kg used in 2014 for combined agricultural and veterinary use. We discuss how we can change our approach to parasite control in our pets by adopting a Test Before You Treat approach that's used in Scandinavia where Vets only prescribe treatments if an animal actually has fleas. Certainly where wormers are also concerned (similarly penetrating waterways and the landscape), there's an easy alternative simply by testing your pet's poop. If no worms are found, why give your dog a wormer? One of the sticking points of the discussion is that the market for parasite control in the vet industry is valued at £170 million.  We chat about how practices could recoup this revenue in other proactive ways. Instagram: @the_environmental_worrierWebsite: vetsustain.orgIf you love A Dog's Life and would like to help support the show why not become a Patreon backer where you can also have access to some exclusive content. If you want to move your dog to a raw diet or even switch brands we wholly recommend Paleo RidgeFor more about Anna go to annawebb.co.ukMusic and production by Mike Hanson for Pod People ProductionsCover art by JaijoCover photo by Rhian Ap Gruffydd at Gruff PawtraitsTo advertise on or sponsor A Dog's Life email: info@theloniouspunkproductions.com

English Edition: In this last episode for the ByteSized RSE "miniseries" we talk about AI assisted coding - and the (long) history how engineers tried to come up with assisting tools to make our code better and more robust. My guest is Liam Gao from Imperial College, London, UK. Links:https://github.com/features/copilot  GitHub Co-Pilothttps://huggingface.co HuggingFace another AI toolhttps://spacelift.io/blog/ai-coding-assistant-tools a summary of current tools (non exhaustive)https://platform.openai.com/docs/guides/prompt-engineering OpenAI's take on prompt engineeringhttps://www.promptingguide.aihttps://web.archive.org/web/20121022091418/http://www.stanford.edu/~learnest/spelling.pdf some of the attempts to come up with spelling checkshttps://en.wikipedia.org/wiki/Code_completionhttps://www.gnu.org/software/emacs/ Good old Emacshttps://en.wikipedia.org/wiki/Vi_(text_editor) vi editor (not for the faint hearted)https://winworldpc.com/product/turbo-pascal/7x Borland's Turbo Pascal with IDEhttps://survey.stackoverflow.co/2024/ Stackoverflow survey from 2024 with ca 65000 respondents And here the YouTube clips mentionedhttps://www.youtube.com/watch?v=MvEXkd3O2ow Cypher musing why he didn't take the "blue pill"https://www.youtube.com/watch?v=L0mRMp2kbQY Star Trek TNG, S3E6 - Geordie LaForge talking to the computerGet in touchThank you for listening! Merci de votre écoute! Vielen Dank für´s Zuhören! Contact Details/ Coordonnées / Kontakt: Email mailto:peter@code4thought.org UK RSE Slack (ukrse.slack.com): @code4thought or @piddie US RSE Slack (usrse.slack.com): @Peter Schmidt Mastodon: https://fosstodon.org/@code4thought or @code4thought@fosstodon.org Bluesky: https://bsky.app/profile/code4thought.bsky.social LinkedIn: https://www.linkedin.com/in/pweschmidt/ (personal Profile)LinkedIn: https://www.linkedin.com/company/codeforthought/ (Code for Thought Profile) This podcast is licensed under the Creative Commons Licence: https://creativecommons.org/licenses/by-sa/4.0/

In this week's MBA Admissions podcast we began by discussing the Round 2 activity on LiveWire; UNC / Kenan Flagler, Yale SOM and Georgetown / McDonough were among the top MBA programs scheduled to release Round 2 decisions last week. For this upcoming week, IESE, Harvard Business School, Northwestern / Kellogg, Columbia, Chicago / Booth, Berkeley / Haas, UCLA / Anderson, Texas / McCombs, Washington / Foster, Boston College / Carroll, Michigan State / Broad, Imperial College and London Business School are releasing their final decisions. Graham highlighted the Spring Survey that Clear Admit conducts each season. These surveys are important to understand the decisions of each applicant cohort. Here is the link for this season's survey: https://bit.ly/casurvey25 Graham noted that we have now nearly finalized the line-up for our Application Overview series of virtual events in May. These events will be hosted on May 6 and 7, and May 20 and 21. Signups are here: https://bit.ly/appoverview25 Sandwiched in the middle of these events is Clear Admit's MBA admissions fair in Boston, on May 14th. Twenty-four of the top 25 U.S.-based MBA programs are planning to attend. Signups for this event are here: https://bit.ly/mbafair2025 May truly kicks off the new season of MBA admissions at Clear Admit! Graham mentioned a recently published admissions tip that offers a primer on the Executive Assessment test. This article is a result of the queries we are seeing on the Ask Clear Admit AI bot tool. Graham then highlighted a Real Humans alumni spotlight, an alum from NYU / Stern working at PepsiCo. For this week, for the candidate profile review portion of the show, Alex selected three DecisionWire entries: This week's first MBA admissions candidate is choosing between Dartmouth / Tuck, Duke / Fuqua, and UVA / Darden. They want to work in consulting on the west coast after business school. This week's second MBA candidate is choosing between Chicago / Booth's EMBA program and Cambridge / Judge's full-time program. They are from Japan and wish to begin a career in the United States. The final MBA candidate is deciding between Cornell / Johnson, Dartmouth / Tuck, and Michigan / Ross. They want to work in tech in New York City. They have a $100k scholarship offer from Ross, and a $30k offer from Johnson. This episode was recorded in Paris, France and Cornwall, England. It was produced and engineered by the fabulous Dennis Crowley in Philadelphia, USA. Thanks to all of you who've been joining us and please remember to rate and review this show wherever you listen!

Morgan McMonagle, Consultant Vascular and Trauma Surgeon, HSE South Hospital Group (Waterford) and the Royal College of Surgeons in Ireland, and formerly Consultant Vascular and Lead Trauma Surgeon, St Mary's Hospital and Imperial College, London

Chris Timmerman is a neuroscientist with a deep interest in phenomenology—what's actually happening in our minds during psychedelic experiences. He leads the DMT Research Group at Imperial College, where he's found that a single psychedelic experience can transform a person's belief system, often turning materialists into panpsychists. In this wide-ranging conversation, Steve talks with Chris about everything from fractals and ayahuasca ceremonies to whether scientists who study psychedelics should talk openly about their own experiences.Original Air Date: March 01, 2025Guests: Chris TimmermanMore from Luminous: ttbook.org/luminous

In this episode, Iain Beardsell and Natalie May speak with neurosurgeon Mark Wilson at the London Trauma Conference. Mark provides an in-depth look at the evolution of the GoodSAM app over the past decade. Initially designed to alert off-duty trained individuals to assist in emergencies, particularly for cardiac arrests and impact brain apnoea, the app has grown to include applications in police services, public health during COVID-19, and community volunteer efforts.   It employs advanced technology, such as real-time video guidance and AI, to offer immediate assistance and improve outcomes in medical emergencies and other crises.   Mark's insights shed light on how this innovative platform is saving lives and transforming emergency and public response systems worldwide.   00:00 Introduction and Reunion   00:47 The GoodSAM App: A Decade of Evolution   01:52 GoodSAM's Impact on Cardiac Arrests   02:09 Expanding GoodSAM: Police and Community Involvement   02:35 How GoodSAM Works   05:54 GoodSAM's Role During COVID-19   13:42 The Future of GoodSAM: AI and Community Support   15:04 How to Get Involved with GoodSAM   16:26 Conclusion and Final Thoughts The Guest Mark is a Consultant Neurosurgeon and Pre-Hospital Care Specialist working at both Imperial College (mainly St Mary's Major Trauma Centre) and as an Air Ambulance doctor.  He am a Clinical Professor specialising in Brain Injury at Imperial and Honorary Professor of Pre-Hospital Care (the Gibson Chair) at the Faculty of Pre-Hospital Care, Royal College of Surgeons, Edinburgh.  His specialist areas are acute brain injury (mostly traumatic brain injury) and its very early management. He is co-director of the Imperial Neurotrauma Centre and am co-founder of GoodSAM, a revolutionary platform that alerts doctors, nurses, paramedic and those trained in basic life support to emergencies around them.  Mark have worked extensively overseas (India, Nepal, South Africa, as a GP in Australia, Researcher for NASA and as an expedition doctor on Arctic and Everest expeditions). He also wrote The Medics Guide to Work and Electives Around the World. His research is mainly into the brain in trauma and in hypoxia (using it as an injury model) in humans.

It has been a cold start to the year and for many that means the heating's on, windows are shut and we're drying clothes inside the house. For many people, mould becomes a major concern in winter and the health problems mould can cause have been under more scrutiny since the death of two-year-old Awaab Ishak who died in 2020 from long-term exposure to mould at his home in Rochdale.At Imperial College London a study called WellHome is underway to monitor levels of mould and other indoor pollutants in homes across the west of the capital. Presenter James Gallagher meets Mum of four Roxanne who had monitoring equipment installed in her house to collect data that could lead to guidance on housing quality and inform how healthcare professionals look for and treat conditions affected by mould. Joining James at Roxanne's is WellHome's Dr Athena Trachalaki, a Respiratory Registrar with Imperial College NHS trust. With her, to go through all the pollutants that pose a risk to our health indoors is WellHome lead and Professor of Community Health and Policy at Imperial College, Frank Kelly. Dr Jonathan Grigg, Professor of Paediatric Respiratory and Environmental Medicine at Queen Mary University, London, tells James it could be the end of the line for the gas cooker, and Professor Alastair Lewis who is Professor of Atmospheric Chemistry at the University of York takes a virtual tour of James's home to discuss all the ways James could be cleaning up the air he breathes. Presenter: James Gallagher Producer: Tom Bonnett Editor: Holly Squire

1/2: #HOTEL MARS; Mars Sample Return by 2040. David Southwood, Imperial College. David Livingston 1920

2/2: #HOTEL MARS; Mars Sample Return by 2040. David Southwood, Imperial College. David Livingston 1925

GOOD EVENING: SPECIAL REPORT: THE FIRES OF LA. From the Mexican Border to the Hughes Fire north of Santa Clarita. #PacificWatch: #VegasReport:  @JCBliss. 1930 Australia CBS EYE ON THE WORLD WITH JOHN BATCHELOR FIRST HOUR 9-915 #UKRAINE: Can Europe field a military deployment to Ukraine? Anatol Lieven, Quincy Institute 915-930 #UKRAINE: Can Europe field a military deployment to Ukraine? Anatol Lieven, Quincy Institute 930-945 BIG TECH: Back to the office. #SCALAREPORT: Chris Riegel CEO, Scala.com @Stratacache 945-1000 #NAVY: Overruns and delays for the Constellation Class & & What is to be done? SECOND HOUR 10-1015 #Anti-semitism: The global poll alarm. Marian Rosenberg, ADL, Malcolm Hoenlein @Conf_of_pres @mhoenlein1 1015-1030 #ISRAEL: Ceasefire pause. Or Issachar, IDSF.org, Malcolm Hoenlein @Conf_of_pres @mhoenlein1 1030-1045 #HOSTAGES: Held in an UNWRA Shelter. Malcolm Hoenlein @Conf_of_pres @mhoenlein1 1045-1100 Allies: Azerbaijan to join Abraham Accords. Zeev Khanin, Bar-Ilan University. Malcolm Hoenlein @Conf_of_pres @mhoenlein1 THIRD HOUR 1100-1115 #VENEZUELA: Trading sanctions for oil and migrants. Mary Anastasia O'Grady, WSJ 1115-1130 #ELECTRICITY: Data Center demands on the brittle grid. Bud Weinstein, RealClearEnergy 1130-1145 #GAZA: Hamas celebrates & What is to be done? Cliff May FDD 1145-1200 #UKRAINE: Deal-making with the needful Kremlin. Russell Berman, Hoover Institution FOURTH HOUR 12-1215 #CANADA: The imminent election. Conrad Black, National Post 1215-1230 #QUANTUM COMPUTING RACE. BRANDON WEICHERT, NATIONAL INTEREST 1230-1245 1/2: #HOTEL MARS; Mars Sample Return by 2040. David Southwood, Imperial College. David Livingston 1245-100 am 2/2: #HOTEL MARS; Mars Sample Return by 2040. David Southwood, Imperial College. David Livingston

In this week's MBA Admissions podcast we began by discussing Round 2 activity on LiveWire; this upcoming week we have two more application deadlines, Imperial College and Boston College / Carroll. Last week, we saw more interview invitations rolling out for UVA / Darden, Dartmouth / Tuck, Yale SOM, Northwestern / Kellogg and CMU / Tepper. We then discussed the roll out of Clear Admit's latest innovation, our “Ask Clear Admit” AI chat bot. We are excited to get customer feedback and hope this new tool will become a “best in class” for chatbots that are specifically trained on MBA admissions-related content. You can find the chatbot here: https://ai.clearadmit.com Graham noted two upcoming webinar series. The first is for Deferred Admissions candidates, with signups here: https://bit.ly/de0225 The first webinar in this series, on February 5, features Berkeley / Haas, UPenn / Wharton and Stanford. The second webinar series is for Masters in Management candidates, with signups here: https://bit.ly/mim0225 Graham highlighted two admissions tips. The first admissions tip focuses on the role of letters of support, and how they are different to letters of recommendation. The second admissions tip focuses on group interviews like the Wharton team-based discussion exercise. Graham also noted two Real Humans stories from Manchester / Alliance and Emory / Goizueta's MIM program. For this week, for the candidate profile review portion of the show, Alex selected two ApplyWire entries and one DecisionWire entry: This week's first MBA admissions candidate is based in India and working at one of the MBB firms. They have super numbers (335 GRE, 3.94 GPA) and are planning ahead for a future admissions season. This week's second MBA candidate also has a very strong profile (331 GRE, 3.7 GPA), and works for an MBB firm in the United States. Their passion appears to be in the urban mobility space. The final MBA candidate is deciding between Columbia, Stern, Yale SOM and a few other top MBA programs. They also have very good scholarship offers. They are seeking a career in social impact, in New York City. This episode was recorded in Paris, France and Cornwall, England. It was produced and engineered by the fabulous Dennis Crowley in Philadelphia, USA. Thanks to all of you who've been joining us and please remember to rate and review this show wherever you listen!

Send us a textIn this episode of Causes or Cures, Dr. Eeks chats with Dr. Lorenzo Pasquini and Hannes Kettner about their groundbreaking research on the effects of psychedelics in older adults. They delve into their shared interest in exploring psychedelics as a potential avenue for improving mental health and well-being in this population, where better treatments are urgently needed. The conversation covers the research process, details about the psychedelic retreats attended by participants, and the substances used. They also share key outcomes related to participants' well-being and discuss exciting future directions for their work.Dr. Pasquini is Assistant Professor of Neurology at UCSF whose research focuses on the brain's role in emotional states and social behavior. Using neuroimaging and neurophysiological techniques, he explores how these systems change with aging, neuropsychiatric diseases, and novel interventions like psychedelics. Hannes Kettner is a researcher and PhD candidate at the Centre for Psychedelic Research, Department of Brain Sciences at Imperial College, London. This episode is sponsored by Greco Gum, the all-natural chewing gum for your mouth and gut that is made from only ONE ingredient! Visit GrecoGum.com and use code ERIN15 to get 15% off your first order.*New* SUBSCRIBE for the Causes or Cures+ Bonus Episodes (now posted) & Monthly Live Q&As! You can contact Dr. Eeks at bloomingwellness.com.Follow Eeks on Instagram here.Or Facebook here.Or X.On Youtube.Or TikTok.SUBSCRIBE to her monthly newsletter here.Support the show

Lauren Laverne talks to Dr Nicola Fox in a programme first broadcast in 2023. Dr Nicky Fox is only the second woman to hold the post of Head of Science at NASA since the agency was founded in 1958. She has responsibility for around a hundred missions which are investigating the mysteries of outer space. These missions are tackling questions such as how do hurricanes form and are we alone in the universe.Nicky was born in Hitchin in Hertfordshire and her father introduced her to the wonders of space when she was just a few months old. In 1969 he lifted her out of her cot to watch the television coverage of the Apollo 11 mission when Neil Armstrong walked on the moon. Nicky's enduring fascination with the cosmos led her to study physics at Imperial College in London.After completing her PhD she took up a post-doctoral fellowship at NASA's Goddard Space Flight Centre in Maryland. In 2010 she became the project scientist for the Parker Solar Probe, humanity's first mission to a star, which launched in 2018 and is still flying through the sun's atmosphere collecting data. Recently she oversaw the Osiris-Rex mission which brought back the first asteroid samples from deep space.In 2021 Nicky was awarded the American Astronautical Society's Carl Sagan Memorial Award for her leadership in the field of Heliophysics.DISC ONE: The Best – Tina Turner DISC TWO: Livin' On A Prayer - Bon Jovi DISC THREE: Lara's Theme - MGM Studio Orchestra, composed and conducted by Maurice Jarre DISC FOUR: Danny Boy - Andy Williams DISC FIVE: When You Know - Shawn Colvin DISC SIX: (Reach Up for the) Sunrise - Duran Duran DISC SEVEN: Boulevard of Broken Dreams - Green Day DISC EIGHT: Canyon Moon - Harry StylesBOOK CHOICE: Pale Blue Dot by Carl Sagan LUXURY ITEM: Lego CASTAWAY'S FAVOURITE: Boulevard of Broken Dreams - Green DayPresenter Lauren Laverne Producer Paula McGinley

In this week's MBA Admissions podcast we began by discussing the activity of MBA LiveWire; Duke / Fuqua released its Round 1 interview invites last week, along with other programs that continue to roll out these decisions. Upcoming this week, IESE, SMU / Cox, Georgia Tech / Scheller and Imperial College are scheduled to release their Round 1 decisions. Graham highlighted the upcoming webinar series for Masters in Management programs, which begins on December 3, and includes Duke / Fuqua, Emory / Goizueta and Notre Dame / Mendoza. Signups are here: https://bit.ly/camim24 Graham also noted the Clear Admit survey that's in the field, and focuses on issues related to building relationships with MBA program participants. The survey is here: https://bit.ly/casurveyfall24 Graham discussed a presentation he is helping to put together for an upcoming GMAC conference, which addresses how MBA admissions adcom are using Gen AI in their admissions process. There is no doubt that admissions workflows will be impacted with this exciting technology shift. We then discussed the introduction of Clear Admit's incentive scheme to encourage more community activity on the Wires platforms. This season, we are seeing a higher level of engagement, which is very exciting. Graham then highlighted a recently published focus on two Stern MBAs who are veterans, in honor of veterans' day. Finally, we discussed three Real Humans stories, focused on MBA students at UPenn / Wharton, Maryland / Smith and Cambridge / Judge. For this week, for the candidate profile review portion of the show, Alex selected three ApplyWire entries: This week's first MBA admissions candidate is a reapplicant from last season. She has a strong focus on the education sector, which ties well with her long-term goal. She has a super GPA of 3.82, but her GRE score is a little less prominent at 323. This week's second MBA candidate is a deferred-admissions candidate. They have a perfect GRE score of 340 and appear to have all the pre-conditions for a strong profile. They are targeting all the top 7 MBA programs; we think they can shorten that list. The final MBA candidate has a perfect GPA of 4.0. They work in audit in Florida, and are planning to apply next season, with three years of experience. They also have decent activities outside of work. We discussed their application strategy and things they can do now, to improve their overall profile. This episode was recorded in Paris, France and Cornwall, England. It was produced and engineered by the fabulous Dennis Crowley in Philadelphia, USA. Thanks to all of you who've been joining us and please remember to rate and review this show wherever you listen!

The Healing Journey of Psilocybin with Tara Portelli Tara Portelli CNHP, CHN, CHt, PCP(Psilocybin Guide, Founder) As founder of Arcadia Healing Sanctum, Tara Portelli has incredible success with her work in the field of Psilocybin Therapy in the retreat setting. She has had the opportunity to work with many high profile clients such as the Comptroller for many UK Ambassadors, a top Robotics Surgeon and numerous medical professionals including, doctors, surgeons, nurses, from all over the world. Her work has extended to first responders, war veterans and people who have limited success with conventional treatments. As founder of Arcadia Healing Sanctum, the reputation her organization has withheld has been recognized by the prestigious, Imperial College of London and now has become an affiliate organization, supporting ongoing research in the field of Psychedelics for mental health. Tara stumbled into her experience with Psilocybin, while on a self healing journey in Tulum, Mexico. As a former Paramedic who has suffered with PTSD, anxiety and some depression, she didn't even know how deep her pain was, until she had her first full dose of Psilocybin. Her experience left her with a deep sense of self and a feeling of peace that she had never experienced before. Working in Emergency services for 9 years, she saw an increasing rise in mental health and human suffering, as people become prisoners of their own minds and we enter into a “mental health crises”. She started working with this medicine under the guidance of a mushroom healer and began helping others through their own journeys to healing. She studied Psychology and Cultural Anthropology at the University of Calgary and then went on to train in Paramedicine, holding a A-EMCA, license as a Primary Care Paramedic (PCP), practising for nine years. In addition, she holds a credentials as a Certified Natural Health Professional (CNHP), Certified Holistic Nutritionist (CHN) and as a Clinical Hypnotist (CHt), training under renowned psychotherapist, Debbie Papadakis. She is has the ability of helping people dive deep into the subconscious mind and healing the relationship with the true self, as well as healing trauma. She has experience working in a Private Holistic treatment facility for mental health and addictions, as well as a family history of mental illness, creating a very deep and passionate affinity for her work. Tara understands psilocybin and the function it can play on a physiological level. In 2020, she aligned herself with Therapsil, a non-profit organization, advocating for Psilocybin therapy for terminal patients who were suffering from end-of-life distress. She was part of the team that successfully gained the first legal access to Psilocybin for terminal patients in Canada. In the right setting, dose and space, this medicine can offer a very life changing experience to those in need. Tara holds a loving, warm and very safe space for those who are ready to take this journey. Website:

Dr. Jordan B. Peterson sits down with author and founder of the Flow Genome Project, Jamie Wheal. They discuss the death of God as it can be understood in the secular world, the new rise of Pharisees across mainstream religions, how to guard the proper aim against human corruption, and the true pathology of the culture wars — and who is leading it downward. Jamie Wheal is the author of “Recapture the Rapture: Rethinking God, Sex and Death In a World That's Lost Its Mind” and the Pulitzer-nominated “Stealing Fire: How Silicon Valley,” “Navy SEALs,” and “Maverick Scientists Are Revolutionizing the Way We Live and Work.” He is also the founder of the Flow Genome Project, an international organization dedicated to the research and training of peak performance. His work and ideas have been covered in The New York Times, Financial Times, Wired, Entrepreneur, Harvard Business Review, Forbes, Inc., and TED. He has spoken at Stanford University, MIT, the Harvard Club, Imperial College, Singularity University, the U.S. Naval War College and Special Operations Command, Sandhurst Royal Military Academy, the Bohemian Club, and the United Nations. This episode was filmed on September 8th, 2024  - Links - For Jamie Wheal: “Recapture the Rapture” (Book) https://www.recapturetherapture.com/ Flow Genome Project https://www.flowgenomeproject.com/

Wow, it must be Wednesday! Big Pharma Cover-Ups? Teen on SSRIs takes the life of her own Mother, NYC Covid Czar's Shocking Confession, and the Failure of Lockdown Science Exposed. We're going to dive into the tragic case of a 14-year-old girl who switched SSRIs before committing a horrific crime, and the alarming revelations of NYC's Covid Czar caught admitting to forced vaccinations and scandalous behavior. Plus, we reveal how the Imperial College's lockdown model was worse than anyone knew, as Prof. Neil Ferguson defends the UK's disruptive strategyWhat does God's Word say? 2 Timothy 4:3 NIV 3 For the time will come when people will not put up with sound doctrine. Instead, to suit their own desires, they will gather around them a great number of teachers to say what their itching ears want to hear.Episode Links:Big Pharma? 14-year-old girl on SSRIs changes medication—a week later she murders her mother and invites friend over to view the dead body…CAUGHT: NYC Covid Czar Admits Forcing Vaccines & Having Drug-Fueled Sex PartiesThe Failure of Imperial College Modeling Is Far Worse than We KnewProf. Neil Ferguson defends UK Coronavirus lockdown strategyDemetre at the White House yesterday speaking from the press podium downplaying Monkeypox as “just an infection”Big Pharma? 14-year-old girl on SSRIs changes medication—a week later she murders her mother and invites friend over to view the dead body…CAUGHT: NYC Covid Czar Admits Forcing Vaccines & Having Drug-Fueled Sex PartiesCAUGHT: NYC Covid Czar Admits Forcing Vaccines & Having Drug-Fueled Sex PartiesThe Failure of Imperial College Modeling Is Far Worse than We KnewProf. Neil Ferguson defends UK Coronavirus lockdown strategyDemetre at the White House yesterday speaking from the press podium downplaying Monkeypox as “just an infection”Alan's Soaps https://www.alansartisansoaps.comUse coupon code ‘TODD' to save an additional 10% off the bundle price.Bioptimizers https://bioptimizers.com/toddStart your journey to better health with MassZymes. Visit bioptimizers.com/todd today to get your MassZymes 10% off.  Bonefrog https://bonefrogcoffee.com/toddMake Bonefrog Cold Brew at home!  Use code TODD at checkout to receive 10% off your first purchase and 15% on subscriptions.Bulwark Capital Bulwark Capital Management (bulwarkcapitalmgmt.com) Join Zach Abraham for Bulwark Capital's Free Live Webinar Tomorrow at 3:30 Pacific.  Call 866-779-RISK or go to KnowYourRiskRadio.com to register today!EdenPURE https://edenpuredeals.comUse code TODD3 to save $200 on the Thunderstorm Air Purifier 3-pack.GreenHaven Interactive   https://greenhaveninteractive.comGet more customers. Dominate Google. Renue Healthcare https://renue.healthcare/toddYour journey to a better life starts at Renue Healthcare. Visit renue.healthcare/Todd